A patent law change pushed by the pharmaceutical industry could cost federal health-care programs $1.3 billion over a decade by delaying new generic drugs, the Congressional Budget Office estimates.
WSJ.com: What's News US, Wall Street Journal
Mon, 08/31/2015 - 7:28pm
A patent law change pushed by the pharmaceutical industry could cost federal health-care programs $1.3 billion over a decade by delaying new generic drugs, the Congressional Budget Office estimates.